首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   2240篇
  免费   189篇
  国内免费   242篇
  2024年   1篇
  2023年   27篇
  2022年   66篇
  2021年   113篇
  2020年   73篇
  2019年   114篇
  2018年   109篇
  2017年   75篇
  2016年   97篇
  2015年   153篇
  2014年   161篇
  2013年   151篇
  2012年   226篇
  2011年   177篇
  2010年   112篇
  2009年   91篇
  2008年   112篇
  2007年   96篇
  2006年   83篇
  2005年   76篇
  2004年   49篇
  2003年   53篇
  2002年   59篇
  2001年   35篇
  2000年   32篇
  1999年   48篇
  1998年   19篇
  1997年   31篇
  1996年   21篇
  1995年   29篇
  1994年   30篇
  1993年   16篇
  1992年   35篇
  1991年   22篇
  1990年   19篇
  1989年   14篇
  1988年   11篇
  1987年   4篇
  1986年   4篇
  1985年   7篇
  1984年   11篇
  1983年   6篇
  1982年   1篇
  1981年   2篇
排序方式: 共有2671条查询结果,搜索用时 15 毫秒
991.
从葡萄糖异构酶产生菌──玫瑰红链霉菌336中分离得到质粒pSR336。经电泳检测和电镜观察证实,存在共价闭合超螺旋和开环两种分子构型,分子量约为6.35kb,拷贝数约为130。采用高温(40℃),吖啶橙、溴化乙锭和SDS等物理、化学因素消除pSR336,均未获得质粒消除株,表明pSR336质粒是非常稳定的。用变铅青链霉菌TK21作受体,进行平皿杂交以检测pSR336的接合转移能力,未观察到麻点(pock)的形成。用HindⅢ分别酶切pSR336和pIJ486,连接得到一个嵌合质粒pIR30,检测玫瑰红链霉  相似文献   
992.
本文旨在研究熊果酸对低分化鼻咽癌细胞氯通道的激活作用,以及熊果酸对其细胞容积的影响。采用膜片钳技术记录熊果酸激活的鼻咽癌细胞(CNE-2Z)全细胞氯电流,应用离子置换、改变细胞外渗透压、氯通道阻断剂等观察熊果酸诱导的氯电流的特性,活细胞动态图像分析技术测量细胞容积变化。结果显示,等渗条件下可记录到CNE-2Z细胞微弱且稳定的背景氯电流,细胞外灌流熊果酸可浓度依赖性(1~100nmol/L)诱发氯电流的产生,在±80mV电压钳制下,100nmol/L熊果酸激活的氯电流的平均电流密度为(78.92±6.39)pA/pF和(59.86±4.86)pA/pF,该电流具有较明显的外向优势,不表现明显的时间依赖性和电压依赖性失活。该电流翻转电位为(4.83±0.30)mV,较接近Cl平衡电位(0.9mV)。熊果酸激活的氯通道对不同阴离子的通透性为:Cl-=I->Br->葡萄酸根离子。该电流具有容积敏感性,可被细胞外高渗透压显著抑制;氯通道阻断剂他莫昔芬(tamoxifen)、5-硝基-2-(3-苯丙胺)苯甲酸[(5-nitro-2-(3-phenylpro-pylamino)benzoic acid,NPPB]可抑制该电流。细胞外灌流熊果酸1h后,细胞容积减小,氯通道阻断剂NPPB可抑制该容积变化。以上结果提示,熊果酸可以激活低分化鼻咽癌细胞的氯通道,使Cl外流,进而引起细胞容积减小。  相似文献   
993.
本实验用CaCl_2溶液对香蕉(Musa acuminata cf. 'Dwarf Davendish')组织进行真空浸透处理,研究Ca~(2 )对香蕉采后乙烯释放、EFE活性、ACC水平以及ACC/MACC比值的影响。结果表明,Ca~(2 )处理可抑制香蕉果皮和果肉组织乙烯生成,对抑制果皮的乙烯生成尤为明显。Ca~(2 )处理还可降低内源ACC水平,抑制EFE活性。结果还显示,Ca~(2 )处理对组织中ACC/MACC比值有一定影响。  相似文献   
994.
采用末端终止法对蓝藻类颤藻科Oscilatoriasp.rDNA16S-23S基因间隔区进行了序列测定,获得了Oscilatoriasp.rDNA基因间隔区427个核苷酸,其中包含1个异亮氨酸tRNA基因(tRNAIle)。并通过计算机联网从国际分子生物学数据弹库中获取颤藻科其它种的rDNA基因间隔区序列,通过比较分析,从分子水平对颤藻科Oscilatoriaceae属间的某些分类学问题进行了讨论,并根据序列中核苷酸差异值探讨了颤藻科属间界定的分子标准。提出了rDNA基因间隔区是良好的分子标记,可用于“赤潮”或“水华”蓝藻专一性核酸分子探针的研制  相似文献   
995.
FOXO 蛋白的修饰与细胞凋亡和癌变   总被引:6,自引:0,他引:6  
Fox 蛋白家族是 2000 年才发布统一命名的蛋白质家族 . 由于其在生物体内所起的重要作用,已迅速成为生命科学研究的热点 . 目前,已经发现其家族成员有 100 多种,其中, FOXO 亚家族在动物细胞的凋亡中起重要作用 . 细胞凋亡与动物的长寿、繁殖、代谢、肿瘤发生及免疫有重要关系,对 Forkhead (Fox) 蛋白分子的命名进行了回顾、对其分类与结构特征进行了总结,并重点对 FOXO 的化学修饰、活性调节及其在细胞凋亡和肿瘤发生中的作用进行了综述 .  相似文献   
996.
盘针孢菌发酵及其胞外多糖抗氧化活性   总被引:1,自引:0,他引:1  
叶明  李世艳  张利兵  蒋艳  庄文颖 《微生物学报》2008,48(10):1398-1402
[目的]研究盘针孢菌的发酵条件及其胞外多糖(EPS)抗氧化活性.[方法]分别研究碳源、氮源、生长因子、pH值和培养时间等条件对盘针孢菌多糖产量的影响作用,并通过测定其多糖的还原能力及对羟自由基(·OH)和1,1-二苯基苦基苯肼(DPPH)自由基的清除作用研究该多糖的抗氧化活性.[结果]盘针孢菌多糖发酵的最佳条件为20%的马铃薯浸汁,20g/L麦芽糖,5 g/L(NH4)2SO4,0.01 g/L L-胱氨酸,pH 5.0,25℃下培养10 d.在此条件下,多糖产量达到37.52 mg/L,与在基础发酵培养基条件下相比,其多糖产量提高了84.10%.盘针孢菌多糖对·OH和DPPH自由基均有较好的清除作用,在多糖浓度为50 mg/L时,对·OH的清除率达到50.81%;多糖浓度为20 mg/L时,对DPPH自由基的清除率达到14.21%.[结论]发酵条件对盘针孢菌多糖代谢具有重要的调控作用,且该多糖具有明显的抗氧化活性.  相似文献   
997.
We previously reported coreceptor switch in rhesus macaques inoculated intravenously with R5 simian-human immunodeficiency virus SF162P3N (SHIVSF162P3N). Whether R5-to-X4 virus evolution occurs in mucosally infected animals and in which anatomic site the switch occurs, however, were not addressed. We herein report a change in coreceptor preference in macaques infected intrarectally with SHIVSF162P3N. The switch occurred in infected animals with high levels of virus replication and undetectable antiviral antibody response and required sequence changes in the V3 loop of the gp120 envelope protein. X4 virus emergence was associated with an accelerated drop in peripheral CD4+ T-cell count but followed rather than preceded the onset of CD4+ T-cell loss. The conditions, genotypic requirements, and patterns of coreceptor switch in intrarectally infected animals were thus remarkably consistent with those found in macaques infected intravenously. They also overlapped with those reported for humans, suggestive of a common mechanism for coreceptor switch in the two hosts. Furthermore, two independent R5-to-X4 evolutionary pathways were identified in one infected animal, giving rise to dual-tropic and X4 viruses which differed in switch kinetics and tissue localization. The dual-tropic switch event predominated early, and the virus established infection in multiple tissues sites. In contrast, the switch to X4 virus occurred later, initiating and expanding mainly in peripheral lymph nodes. These findings help define R5 SHIVSF162P3N infection of rhesus macaques as a model to study the mechanistic basis, dynamics, and sites of HIV-1 coreceptor switch.The human immunodeficiency virus (HIV) enters target cells via binding of the viral envelope glycoprotein to the CD4 receptor, triggering envelope conformational changes that allow for interaction with either the CCR5 or CXCR4 chemokine receptor (1, 3, 8, 15, 16, 18). Most HIV type 1 (HIV-1) transmissions are initiated with CCR5-using (R5) viruses (58, 68). With time, CXCR4-tropic (X4) viruses emerge and coexist with R5 viruses in close to 50% of subtype B-infected individuals, and this is accompanied by a rise in viremia, rapid CD4+ T-cell loss, and progression to disease (4, 7, 11, 34, 57, 65). The mechanistic basis and reasons for HIV-1 coreceptor switch, however, are still not well understood. Several factors including high viral load, low CD4+ T-cell numbers, reduced availability of CCR5+ cells, and progressive immune dysfunction have been proposed as playing important roles (48, 54). Since X4 virus emergence is associated with a faster rate of disease progression, insights into the determinants of HIV-1 coreceptor switch are of interest in understanding viral pathogenesis. Furthermore, with the introduction of CCR5 entry inhibitors as anti-HIV therapeutics (19, 23, 24, 38), there is a need not only to identify the presence of X4 variants in patients when treatment options are considered but also to understand the factors that influence X4 virus evolution. Although the majority of individuals failing on short-term CCR5 antagonist monotherapy harbor preexisting minor X4 variants (71), it is conceivable that given the right conditions and selective forces, inhibiting HIV-1 entry via CCR5 may drive the virus to evolve to CXCR4 usage and exacerbate disease. An animal model that faithfully recapitulates the process of coreceptor switch will be highly useful to study and identify the determinants and conditions that facilitate the change in coreceptor preference. In addition, an animal model provides the opportunity to track the kinetics of coreceptor switching at different anatomical sites, which may inform on the mechanisms of X4 virus emergence.In this regard, we recently reported coreceptor switch in two of nine rhesus macaques (RM) inoculated intravenously with simian-human immunodeficiency virus SF162P3N (SHIVSF162P3N) that bears an HIV-1 CCR5-tropic Env (28, 29). In order to establish a reproducible model for coreceptor switch, however, it was crucial to document additional switching events. Furthermore, since the majority of HIV transmission occurs via mucosal surfaces, it was important to demonstrate coreceptor switch in macaques infected with R5 SHIVSF162P3N by the mucosal route to validate this animal model in studying the in vivo evolution of HIV-1 coreceptor usage. Additionally, the tissue compartment(s) where CXCR4-using viruses evolve and expand is not well characterized. A recent study indicates that the thymus may play an important role in the evolution and/or amplification of coreceptor variants in pediatric HIV infection (56). Since the thymus is the primary source of T lymphopoiesis during early life (45) and since CXCR4 is the predominant coreceptor expressed on thymocytes (33, 64), this organ would seem to provide the ideal milieu for X4 amplification in infants and children. Indeed, we previously showed that whereas X4 SHIV infection of newborn RM resulted in severe thymic involution, R5 SHIV infection induced only a minor disruption in thymic morphology (55), lending support to the idea that the thymus is a preferred site for X4 replication in pediatric HIV infections. Nevertheless, thymopoietic function declines with age (17, 42, 60), and naïve T cells that express high levels of CXCR4 are also enriched in peripheral lymph nodes (5, 27, 36, 66). Thus, the role of the thymus and other lymphoid tissues in HIV-1 coreceptor switch in older individuals remains to be determined. To address these issues, we inoculated adult RM intrarectally (i.r.) with R5 SHIVSF162P3N and performed frequent longitudinal blood and tissue samplings. Our goal was to document changes in coreceptor preference in mucosally infected macaques, as well as to obtain a more detailed picture of the kinetics and site of X4 virus evolution and amplification in vivo.  相似文献   
998.
自由基过度引起的氧化应激是多种疾病发生的因素。连翘花黄色素(forsythia flower yellow pigment, FFYP)中含有大量的抗氧化活性物质,但其对氧化应激的抵抗性仍不清楚。本文首先通过化学方法检测FFYP的体外抗氧化活性;用细胞内抗氧化活性(cellular antioxidant activity,CAA)方法检测FFYP细胞内抗氧化活性;然后以秀丽隐杆线虫(Caenorhabditis elegans,C. elegans)为模型,检测FFYP对线虫氧化应激抵抗力及体内抗氧化指标的影响;用Daf 16和Skn 1突变体线虫和qRT PCR实验探究其作用机制。研究结果表明,FFYP具有1,1-二苯基-2-三硝基苯肼(1,1-diphenyl-2-picrylhydrazyl, DPPH)自由基清除能力,铁离子还原能力和活性氧自由基(reactive oxygen species, ROS)清除能力,并且具有浓度依赖性。用500 μmol/L的胡桃醌提供氧化应激压力时,FFYP能显著提高线虫在氧化应激下的寿命,表明FFYP可以提高线虫对氧化应激的抵抗力。进一步研究发现,FFYP可显著降低线虫体内ROS自由基含量,提高超氧化物歧化酶(superoxide dismutase, SOD)和过氧化氢酶(catalase, CAT)活性,增加还原型谷胱甘肽(glutathione, GSH)含量,表明FFYP通过提高线虫体内抗氧化防御系统活性清除自由基来提高线虫对氧化应激的抵抗力。突变体线虫实验显示,FFYP对线虫延长氧化应激下寿命的效应在Skn-1突变体线虫中完全消失,在Daf-16突变体中效应被减弱。qRT-PCR实验也显示,Daf-16和Skn-1靶基因的表达量均被提高。表明FFYP对线虫氧化应激抵抗力提高的作用是通过Daf-16和Skn-1共同作用。这预示着FFYP具有很好的抗氧化及抗应激药用价值,有潜力成为一种新的有生物活性的天然色素。  相似文献   
999.
大豆球蛋白是大豆种子中主要的贮藏蛋白。它们在某些作物中占种子干重20%以上。已经知道大豆球蛋白由6个亚基组成。每个亚基由一或两个酸性多肽(A)和一个碱性多肽(B)组成,多肽之间由二硫键联结。这些亚基是从编码A-B亚基前体的mRNA合成,然后经过转录后加工剪切形成A肽和B肽。至今所有关于球蛋白的基因结构与表达的报道都集中于栽培大豆上。由于我国有丰富的大豆  相似文献   
1000.
自从20年前光镊技术被Ashkin、Chu及其同事发明[1],该技术已被应用于各种生物学研究并由此获得丰富信息.例如应力下生物高分子的行为[2],DNA连接酶如何译码或如何消化DNA[3~6],动力蛋白如何沿分子轨道移动[7~8],以及RNA和蛋白质分子如何折叠/展开[9~11].通过对单个分子的操纵,光镊技术可用于探索这些生物系统在分子层面的工作模式.在本期222页,Case等描述了该技术的另一精巧应用.揭示了凝聚子蛋白质如何产生紧凑形式的DNA[12].  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号